John P. O’Donnell
- Physiology top 1%
- Adenosine and Purinergic Signaling 10
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 10
- Molecular Medicine top 10%
- Cell Biology top 10%
-
- Receptor Mechanisms and Signaling 6
- Ubiquitin and proteasome pathways 3
- Chemical Synthesis and Analysis 3
-
- Hormonal Regulation and Hypertension 5
- Hormonal and reproductive studies 3
-
- Eicosanoids and Hypertension Pharmacology 3
- Co-authors
- G. Kurt HogaboomJeffrey S. FedanDeepak DalvieDavid P. WestfallAmit S. KalgutkarHolger SondermannHoward D. ColbyJames H. Sherry
- Journals
- European Journal of Pharmacology (8 papers)Biochemical Pharmacology (5 papers)Journal of Medicinal Chemistry (4 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
John P. O’Donnell
64 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Physiology 195
- Pharmacology 144
- Molecular Medicine 72
- Cell Biology 195
- Molecular Biology 671
Countries citing papers authored by John P. O’Donnell
This map shows the geographic impact of John P. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. O’Donnell more than expected).
Fields of papers citing papers by John P. O’Donnell
This network shows the impact of papers produced by John P. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. O’Donnell. The network helps show where John P. O’Donnell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John P. O’Donnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 73 | |
| 6 | 2020 | 1 | |
| 7 | Physical Principles of Membrane Shape Regulation by the Glycocalyxbreakdown → | 2019 | 185 |
| 8 | 2017 | 11 | |
| 9 | 2017 | 26 | |
| 10 | 2010 | 2 | |
| 11 | 2003 | 56 | |
| 12 | 1999 | 9 | |
| 13 | 1999 | 3 | |
| 14 | 1998 | 24 | |
| 15 | 1992 | 38 | |
| 16 | 1989 | 2 | |
| 17 | 1988 | 2 | |
| 18 | TOLBUTAMIDE, AN INHIBITOR OF ATP-SENSITIVE K-CHANNELS, EXCITES CAROTID-BODY CHEMORECEPTORS IN THE CAT | 1987 | 2 |
| 19 | 1986 | 21 | |
| 20 | 1983 | 8 |
About John P. O’Donnell
John P. O’Donnell is a scholar working on Physiology, Pharmacology, Aging, Biochemistry and Internal Medicine, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (6 papers), Hormonal Regulation and Hypertension (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Ubiquitin and proteasome pathways (3 papers), Hormonal and reproductive studies (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Physiology (195 citations), Pharmacology (144 citations), Molecular Medicine (72 citations), Cell Biology (195 citations) and Molecular Biology (671 citations). John P. O’Donnell has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include G. Kurt Hogaboom, Jeffrey S. Fedan, Deepak Dalvie, David P. Westfall, Amit S. Kalgutkar, Holger Sondermann, Howard D. Colby, James H. Sherry, Laura J. Byrnes and Tim Taylor. Their work appears in journals such as European Journal of Pharmacology, Biochemical Pharmacology, Journal of Medicinal Chemistry, Life Sciences and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.